126 related articles for article (PubMed ID: 36286675)
1. [The results of phase III multicenter open randomized controlled study REM-Chol-III-16 in patients with intrahepatic cholestasis syndrome caused by chronic diffuse liver diseases].
Stel'makh VV; Kovalenko AL; Popova VB; Uspenskiy YP; Morozov VG; Belikova TN; Rafalskiy VV; Antonova EA
Ter Arkh; 2021 Dec; 93(12):1470-1476. PubMed ID: 36286675
[TBL] [Abstract][Full Text] [Related]
2. Heptral (ademetionine) in patients with intrahepatic cholestasis in chronic liver disease due to non-alcoholic liver disease: results of a multicentre observational study in India.
Virukalpattigopalratnam MP; Singh T; Ravishankar AC
J Indian Med Assoc; 2013 Dec; 111(12):856-9. PubMed ID: 25154164
[TBL] [Abstract][Full Text] [Related]
3. S-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results.
Ribalta J; Reyes H; Gonzalez MC; Iglesias J; Arrese M; Poniachik J; Molina C; Segovia N
Hepatology; 1991 Jun; 13(6):1084-9. PubMed ID: 2050326
[TBL] [Abstract][Full Text] [Related]
4. [Clinical trial of heptral in patients with chronic diffuse liver disease with intrahepatic cholestasis syndrome].
Podymova SD; Nadinskaia MIu
Klin Med (Mosk); 1998; 76(10):45-8. PubMed ID: 9865018
[TBL] [Abstract][Full Text] [Related]
5. [Effect of hepatoprotector remaxol infusion on liver function in obstructive jaundice model in rats].
Smirnova NG; Chefu SG; Kovalenko AL; Vlasov TD
Eksp Klin Farmakol; 2010 Sep; 73(9):24-7. PubMed ID: 21086649
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis.
Roncaglia N; Locatelli A; Arreghini A; Assi F; Cameroni I; Pezzullo JC; Ghidini A
BJOG; 2004 Jan; 111(1):17-21. PubMed ID: 14687046
[TBL] [Abstract][Full Text] [Related]
7. [A meta-analysis of therapeutic trials with ademetionine in the treatment of intrahepatic cholestasis].
Frezza M
Ann Ital Med Int; 1993 Oct; 8 Suppl():48S-51S. PubMed ID: 8117521
[TBL] [Abstract][Full Text] [Related]
8. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration.
Frezza M; Pozzato G; Chiesa L; Stramentinoli G; di Padova C
Hepatology; 1984; 4(2):274-8. PubMed ID: 6706301
[TBL] [Abstract][Full Text] [Related]
9. Open-label study of ademetionine for the treatment of intrahepatic cholestasis associated with alcoholic liver disease.
Ivashkin VT; Maevskaya MV; Kobalava ZD; Uspenskiy YP; Fominih JA; Rozanov AV; Tolkacheva VV; Sotnikova TI; Alikhanov BA; Gorbacheva IA; Ershova OB; Znakhyrenko AA; Sokolov KA; Sander-Struckmeier S
Minerva Gastroenterol Dietol; 2018 Sep; 64(3):208-219. PubMed ID: 29431335
[TBL] [Abstract][Full Text] [Related]
10. Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis.
Almasio P; Bortolini M; Pagliaro L; Coltorti M
Drugs; 1990; 40 Suppl 3():111-23. PubMed ID: 2081476
[TBL] [Abstract][Full Text] [Related]
11. [Intrahepatic induction of endogenous S-adenosyl-L-methionine against the background of various ways of administration of methionine-succinate complex and its role in drug-induced liver lesion correction].
Sukhanov DS; Petrov AIu; Kovalenko AL; Romantsov MG
Vestn Ross Akad Med Nauk; 2012; (3):86-90. PubMed ID: 22712281
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of melatonin against oxidative stress induced by ligature of extra-hepatic biliary duct in rats: comparison with the effect of S-adenosyl-L-methionine.
López PM; Fiñana IT; De Agueda MC; Sánchez EC; Muñoz MC; Alvarez JP; De La Torre Lozano EJ
J Pineal Res; 2000 Apr; 28(3):143-9. PubMed ID: 10739300
[TBL] [Abstract][Full Text] [Related]
13. A review of the studies on the clinical use of S-adenosylmethionine (SAMe) for the symptomatic treatment of intrahepatic cholestasis.
Coltorti M; Bortolini M; Di Padova C
Methods Find Exp Clin Pharmacol; 1990; 12(1):69-78. PubMed ID: 2179653
[TBL] [Abstract][Full Text] [Related]
14. [Comparative efficacy of clinical use of reamberin, remaxol and ademethionine in patients with tuberculosis of the respiratory organs and liver drug-injury].
Sukhanov DS; Pavlova MV; Iablonskiĭ PK; Vinogradova TI
Antibiot Khimioter; 2013; 58(1-2):13-8. PubMed ID: 24640140
[TBL] [Abstract][Full Text] [Related]
15. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study.
Frezza M; Surrenti C; Manzillo G; Fiaccadori F; Bortolini M; Di Padova C
Gastroenterology; 1990 Jul; 99(1):211-5. PubMed ID: 2188871
[TBL] [Abstract][Full Text] [Related]
16. [Induction of endogenous s-adenosyl-l-methionine in hepatocytes during pharmacological correction of experimental acute toxic and chronic drug-induced liver injury].
Sukhanov DS; Petrov AIu; Kovalenko AL; Romantsov MG
Eksp Klin Farmakol; 2011; 74(10):34-8. PubMed ID: 22238985
[TBL] [Abstract][Full Text] [Related]
17. Low activity of gamma-glutamyl transpeptidase in serum of acute intrahepatic cholestasis.
Kajiwara E; Akagi K; Tsuji H; Murai K; Fujishima M
Enzyme; 1991; 45(1-2):39-46. PubMed ID: 1687217
[TBL] [Abstract][Full Text] [Related]
18. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.
Binder T; Salaj P; Zima T; Vítek L
J Perinat Med; 2006; 34(5):383-91. PubMed ID: 16965225
[TBL] [Abstract][Full Text] [Related]
19. Differentiation between extrahepatic and intrahepatic cholestasis by discriminant analysis.
Fung KP; Lau SP
J Paediatr Child Health; 1990 Jun; 26(3):132-5. PubMed ID: 1976325
[TBL] [Abstract][Full Text] [Related]
20. Chronic liver diseases and the potential use of S-adenosyl-L-methionine as a hepatoprotector.
Mora SI; García-Román J; Gómez-Ñañez I; García-Román R
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):893-900. PubMed ID: 29683981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
